Colorectal liver metastasis: molecular mechanism and interventional therapy

287Citations
Citations of this article
271Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a high morbidity additionally, CRC patients may develop liver metastasis, which is the major cause of death. Despite significant advances in diagnostic and therapeutic techniques, the survival rate of colorectal liver metastasis (CRLM) patients remains very low. CRLM, as a complex cascade reaction process involving multiple factors and procedures, has complex and diverse molecular mechanisms. In this review, we summarize the mechanisms/pathophysiology, diagnosis, treatment of CRLM. We also focus on an overview of the recent advances in understanding the molecular basis of CRLM with a special emphasis on tumor microenvironment and promise of newer targeted therapies for CRLM, further improving the prognosis of CRLM patients.

Cite

CITATION STYLE

APA

Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., … Wen, Y. (2022, December 1). Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduction and Targeted Therapy. Springer Nature. https://doi.org/10.1038/s41392-022-00922-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free